|
|
|
|
|
Rocuronium Bromide EP6.0 API+Intermediates CAS 119302-91-9 |
|
Rocuronium Bromide EP6.0 API+Intermediates |
|
119302-91-9 |
|
We offer Rocuronium Bromide EP6.0 CAS 119302-91-9 with following detail: Rocuronium Bromide EP6.0 CAS£º119302-91-9 molecular formula£ºC32H53N2O4.Br molecular weight£º609.70 Application: Muscular relaxant Specification: Product Rocuronium Bromide Reference standard Specification Of EP6.0 Items Specification Appearance Whitish or yellowish powder Specific optical rotation +28.5¡Æ¢¦+32.0¡Æ eavy metals 10ppm Not more than 10ppm Related substances 1.5%Not more than 1.5% Water content 4.0%Not more than 4.0% Assay 99.0%¢¦101.0% 5alpha- androst-2-en-17-one 963-75-7 Rocuronium intermediate 17-Acetoxy-5a-androsta-2,16-diene 50588-42-6 Rocuronium intermediate (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol 119302-20-4 Rocuronium intermediate (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane 119302-24-8 Rocuronium intermediate Rocuronium is an aminosteroid non-depolarizing (that is, it does not cause initial stimulation of muscles before weakening them) neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Check our website and you can find MSDS of this products:Rocuronium Bromide EP6.0,119302-91-9 |
|
We are very strong in producing: Rocuronium Bromide EP6.0 CAS No: 119302-91-9 Vecuronium Bromide CAS No: 50700-72-6 Pancuronium Bromide CAS No: 15500-66-0 Pipecuronium Bromide CAS No: 52212-02-9 Fasudil hydrochloride CAS No: 105628-07-7 (103745-39-7) Palonosetron Hydrochloride CAS No: 135729-62-3 Dolasetron Mesylate USP3.0 CAS No: 115956-13-3 Darifenacin CAS No: 133099-07-7 Solifenacin CAS No: 242478-37-1 Mitiglinide calcium CAS No:145525-41-3 Zofenopril Calcium CAS No: 81938-43-4 and their intermediates Custom chemical synthesis Chrial medicinal intermediate ANY OEM fine chemical products, pls contacts us . |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|